论文部分内容阅读
急性脑梗死是一种高发病率、高致残率疾病 ,近年来 ,国内外多采用溶栓疗法 ,疗效肯定 ,但因在治疗中有发生出血的可疑 ,医生和家属均有顾虑 ,且部分患者入院时已超过时间窗 ,不能进行溶栓疗法 ,一般疗法效果不甚满意 ,故作者旨在探讨低分子量肝素抗凝疗法的疗效。1 材料与方法
Acute cerebral infarction is a high morbidity and high morbidity disease. In recent years, thrombolytic therapy has been used more at home and abroad, and the curative effect is affirmed. However, due to the suspicion of bleeding during treatment, both doctors and their families have concerns and some Patients admitted to the hospital has exceeded the time window, can not be thrombolytic therapy, the general effect of the treatment is not satisfactory, so the author aims to explore the effect of low molecular weight heparin anticoagulant therapy. 1 materials and methods